Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blair Norfolk

  • Home
  •  
  • Blair Norfolk



  • Most Read
  • Latest Comments
  • Biome probiotics bound for United Kingdom and Ireland, upgrades revenue guidance
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Biome probiotics bound for United Kingdom and Ireland, upgrades revenue guidance
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Biome probiotics bound for United Kingdom and Ireland, upgrades revenue guidance
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Biome probiotics bound for United Kingdom and Ireland, upgrades revenue guidance
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Biome probiotics bound for United Kingdom and Ireland, upgrades revenue guidance
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Biome leaps into Canada as sales in Australia skyrocket
    Biome leaps into Canada as sales in Australia skyrocket
    • News

  • Biome probiotics bound for United Kingdom and Ireland, upgrades revenue guidance
    Biome probiotics bound for United Kingdom and Ireland, upgrades revenue guidance
    • News

  • Biome exceeds $7 million sales revenue target for FY23 thanks to its Activated Probiotics range
    Biome exceeds $7 million sales revenue target for FY23 thanks to its Activated Probiotics range
    • News

  • Biome has a new probiotic approach to acne
    Biome has a new probiotic approach to acne
    • News

  • Demand for obscure wellness products sees strong sales from Eve Health’s probiotic concentrate drinks
    Demand for obscure wellness products sees strong sales from Eve Health’s probiotic concentrate drinks
    • News

  • Biome probiotics bound for United Kingdom and Ireland, upgrades revenue guidance
    • News

    Biome probiotics bound for United Kingdom and Ireland, upgrades revenue guidance

    Unveiling a string of good news to begin 2024, microbiome health company Biome (ASX: BIO) has announced the launch of its Activated Probiotics in major European health retail outlets starting January 2024. Key distributors are CLF in the UK and iiHealthfoods in Ireland, with funding for the expansion coming from Biome’s current working capital. What’s

    Read More
    Public
  • Biome exceeds $7 million sales revenue target for FY23 thanks to its Activated Probiotics range
    • News

    Biome exceeds $7 million sales revenue target for FY23 thanks to its Activated Probiotics range

    Microbiome health company Biome Australia (ASX: BIO) has surpassed its sales revenue target for FY23, reaching an impressive $7 million with half a month of trading still remaining. The accelerated growth in sales revenue during the fourth quarter was primarily driven by the success of Biome’s Activated Probiotics—making up over 90% of the sales as

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.